These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37807062)

  • 1. N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.
    Gan L; Zhao S; Gao Y; Qi Y; Su M; Wang A; Cai H
    Biol Direct; 2023 Oct; 18(1):64. PubMed ID: 37807062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
    Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
    Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma.
    Wu Y; Luo Y; Yao X; Shi X; Xu Z; Re J; Shi M; Li M; Liu J; He Y; Du X
    Cell Biol Toxicol; 2024 Jul; 40(1):58. PubMed ID: 39060874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
    Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
    J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner.
    Ma L; Lin Y; Sun SW; Xu J; Yu T; Chen WL; Zhang LH; Guo YC; Wang YW; Chen T; Wei JF; Zhu LJ
    Oncogene; 2022 Jan; 41(5):692-703. PubMed ID: 34819634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification.
    Zhang Z; Guo J; Gong C; Wu S; Sun Y
    Cancer Biomark; 2024 Feb; ():. PubMed ID: 38427468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N
    Li Y; He L; Wang Y; Tan Y; Zhang F
    Bioengineered; 2022 May; 13(5):11923-11932. PubMed ID: 35546050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination.
    Shen C; Liu J; Xie F; Yu Y; Ma X; Hu D; Liu C; Wang Y
    Cancer Lett; 2024 Jul; 595():217002. PubMed ID: 38823761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.
    Chen X; Lu T; Cai Y; Han Y; Ding M; Chu Y; Zhou X; Wang X
    Cell Mol Biol Lett; 2023 Apr; 28(1):32. PubMed ID: 37076815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification.
    Chen X; Fan R
    J Oral Pathol Med; 2024 Apr; 53(4):266-274. PubMed ID: 38531807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer.
    Zhang Y; Ling Y; Zhou Y; Shi X; Shen F; Zhou J; Chen Y; Yang F; Gu Y; Wang J
    Cancer Control; 2024; 31():10732748241256819. PubMed ID: 38755968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis.
    Li J; Yang J; Chen Z; Liu L; Wang H; Deng Q; Chen Y; Que Y; Fu Z
    Biomol Biomed; 2023 May; 23(3):483-495. PubMed ID: 36373629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Zhou Y; Pei Z; Maimaiti A; Zheng L; Zhu Z; Tian M; Zhou Z; Tan F; Pei Q; Li Y; Liu W
    Cell Death Discov; 2022 Feb; 8(1):83. PubMed ID: 35217651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of POU1F1 promoting the properties of stemness of gastric carcinoma through ENO1-mediated glycolysis reprogramming.
    Tang C; Zhang H; Deng WS; Xiong LQ; Zhou LQ
    Kaohsiung J Med Sci; 2023 Sep; 39(9):904-915. PubMed ID: 37334727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells.
    Shan M; Liu D; Sun L; Yang M; He M; Zhang Y; Xiang L; Lu L; He H; Niu D; Chen L; Li S; Chen A; He F; Wang Y; Lian J
    Cancer Lett; 2024 Mar; 584():216598. PubMed ID: 38224863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIAA1429 Promotes Nasopharyngeal Carcinoma Progression by Mediating m6A Modification of PTGS2.
    Wu L; Zhou Y; Fu J
    Crit Rev Immunol; 2023; 43(4):15-27. PubMed ID: 37830191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.
    Zhang CP; Huang XY
    Hum Cell; 2023 Sep; 36(5):1741-1754. PubMed ID: 37368192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis.
    Hu T; Liu H; Liang Z; Wang F; Zhou C; Zheng X; Zhang Y; Song Y; Hu J; He X; Xiao J; King RJ; Wu X; Lan P
    Theranostics; 2020; 10(9):4056-4072. PubMed ID: 32226539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.